Baotou Dongbao Bio-Tech Co.,Ltd (SHE:300239)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Biological and Biochemical Products		884.93M	974.51M	943.40M	612.17M	448.83M
Biological and Biochemical Products Growth		-9.19%	3.30%	54.11%	36.39%	-8.79%
Total		884.93M	974.51M	943.40M	612.17M	448.83M
Total Growth		-9.19%	3.30%	54.11%	36.39%	-8.79%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
East China		397.89M	480.04M	451.81M	341.59M	228.74M
East China Growth		-17.11%	6.25%	32.27%	49.34%	-
North China		118.01M	170.14M	174.05M	100.00M	75.49M
North China Growth		-30.64%	-2.24%	74.04%	32.47%	-
Central China		61.37M	44.64M	56.76M	73.42M	57.04M
Central China Growth		37.50%	-21.37%	-22.68%	28.71%	-
Southern China		60.49M	75.37M	69.76M	49.87M	51.82M
Southern China Growth		-19.74%	8.03%	39.89%	-3.76%	-
South-West China		77.64M	87.08M	85.27M	25.05M	-
South-West China Growth		-10.84%	2.12%	240.43%	-	-
Northwestern China		49.53M	39.35M	36.83M	11.73M	-
Northwestern China Growth		25.85%	6.85%	214.05%	-	-
Northeast China		35.45M	37.16M	44.60M	9.68M	8.99M
Northeast China Growth		-4.60%	-16.67%	360.54%	7.76%	-
Overseas		84.56M	40.73M	24.31M	816.51K	-
Overseas Growth		107.59%	67.54%	2877.51%	-	-
Other		-	-	-	-	26.75M
Total		884.93M	974.51M	943.40M	612.17M	448.83M
Total Growth		-9.19%	3.30%	54.11%	36.39%	-8.79%

Source: S&P Global Market Intelligence.